Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis.
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol. 2021; 12(3):1001-1019.
View in:
PubMed
subject areas
Animals
Animals
Bile Acids and Salts
Bile Acids and Salts
Cholesterol
Cholesterol
Combined Modality Therapy
Combined Modality Therapy
Dependovirus
Dependovirus
Disease Models, Animal
Disease Models, Animal
Fibroblast Growth Factors
Fibroblast Growth Factors
Fructose
Fructose
Gene Expression Profiling
Gene Expression Profiling
Gene Expression Regulation
Gene Expression Regulation
Genetic Therapy
Genetic Therapy
Genetic Vectors
Genetic Vectors
Male
Male
Methylamines
Methylamines
Mice
Mice
Non-alcoholic Fatty Liver Disease
Non-alcoholic Fatty Liver Disease
Thiazepines
Thiazepines
Treatment Outcome
Treatment Outcome
authors with profiles
Jacob Friedman
Tiangang Li